Transcenta and WuXi Biologics launch strategic collaboration on HiCB tech
Transcenta Therapeutics announced a strategic collaboration with WuXi Biologics to accelerate commercialization of HiCB continuous bioprocessing technologies.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.